睡眠模式和牛皮疾病的风险:从遗传倾向和代谢学学的见解
Ziyu Guo1,2,3,4,5,6, Zehao Luo1,2,3,4,5,6, Shiyu Zhang1,2,3,4,5,6
1Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China.
The British journal of dermatology
|November 15, 2025
概括
睡眠不足显著提高了牛皮病 (PsD) 的风险,特别是在具有高遗传倾向的个体中. 优化睡眠是减少PsD发病率的关键生活方式因素,代谢生物标志物起着调解作用.
科学领域:
- 流行病学 流行病学
- 遗传学 遗传学 是一个
- 代谢学 代谢学 代谢学
背景情况:
- 睡眠模式和牛皮病 (PsD) 发展之间的关系尚未完全理解.
- 调查纵向睡眠影响和潜在的调解因素对于预防PsD至关重要.
研究的目的:
- 检查睡眠模式如何影响患PsD的风险.
- 评估遗传倾向和血清代谢物在睡眠与PsD相关性中的作用.
- 为了确定PsD风险的潜在调解途径.
主要方法:
- 来自英国生物银行的399912名参与者的前性队列研究.
- 考克斯比例危险模型和相互作用分析被用于评估睡眠,遗传风险 (多基因风险评分 - PRS) 和PsD.
- 调解分析确定了血清代谢物,将睡眠模式与PsD风险联系起来.
主要成果:
- 具有良好的睡眠模式和低遗传风险的个体的PsD发病率最低.
- 在PRS和睡眠模式之间发现了显著的乘法和加法相互作用.
- 葡萄糖,PUFA/MUFA比率和性酸酶被确定为部分调解剂.
结论:
- 不良的睡眠模式大大增加了PsD风险,特别是在基因易受影响的个体中.
- 睡眠和PsD之间的关联部分是由炎症和代谢生物标志物介导的.
- 优化睡眠是减少PsD风险的可修改目标.
相关概念视频
Circadian Rhythms and Gene Regulation
4.5K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.5K
Human Genetics
1.4K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.4K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
163
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
163
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
338
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
338
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Factors Affecting Drug Biotransformation: Biological
503
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
503
